Co-Authors
This is a "connection" page, showing publications co-authored by Nassim Kamar and Arnaud Del Bello.
Connection Strength
11.580
-
Anti-SARS-CoV-2 Monoclonal Antibodies in Solid-organ Transplant Patients. Transplantation. 2021 10 01; 105(10):e146-e147.
Score: 0.971
-
Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients. Am J Transplant. 2022 01; 22(1):322-323.
Score: 0.965
-
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients. N Engl J Med. 2021 08 12; 385(7):661-662.
Score: 0.952
-
Kidney transplantation during the COVID-19 pandemic: Potential long-term consequences of an early post-transplant infection. Transpl Infect Dis. 2021 08; 23(4):e13446.
Score: 0.949
-
Acute rejection after anti-SARS-CoV-2 mRNA vaccination in a patient who underwent a kidney transplant. Kidney Int. 2021 07; 100(1):238-239.
Score: 0.942
-
Specific organization for in-hospital belatacept infusion to avoid nosocomial transmission during the SARS-CoV-2 pandemic. Am J Transplant. 2020 10; 20(10):2962-2963.
Score: 0.892
-
Do natural antibodies have a detrimental effect after kidney transplantation? Ann Transl Med. 2018 Aug; 6(16):316.
Score: 0.779
-
High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation. World J Gastroenterol. 2018 Apr 28; 24(16):1795-1802.
Score: 0.765
-
Recurrence of oxalate nephropathy after isolated kidney transplantation for primary hyperoxaluria type 2. Am J Transplant. 2018 02; 18(2):525-526.
Score: 0.741
-
Impact of transplant accessibility for sensitized patients by avoiding unacceptable antigens. Liver Transpl. 2017 07; 23(7):880-886.
Score: 0.723
-
High immunogenicity of a messenger RNA-based vaccine against SARS-CoV-2 in chronic dialysis patients. Nephrol Dial Transplant. 2021 08 27; 36(9):1704-1709.
Score: 0.241
-
Adaptive lymphocyte profile analysis discriminates mild and severe forms of COVID-19 after solid organ transplantation. Kidney Int. 2021 10; 100(4):915-927.
Score: 0.238
-
Safety and Immunogenicity of Anti-SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants. Ann Intern Med. 2021 09; 174(9):1336-1338.
Score: 0.237
-
Conversion From Belatacept to Another Immunosuppressive Regimen in Maintenance Kidney-Transplantation Patients. Kidney Int Rep. 2020 Dec; 5(12):2195-2201.
Score: 0.227
-
Tocilizumab for Hemophagocytic Syndrome in a Kidney Transplant Recipient With COVID-19. Ann Intern Med. 2020 09 15; 173(6):501-503.
Score: 0.221
-
Incidence of Donor-Specific Anti-HLA Antibodies in Non-HLA-Sensitized Patients Given Tacrolimus Once or Twice Daily During the First 2 Years After Kidney Transplant. Exp Clin Transplant. 2019 06; 17(3):313-319.
Score: 0.201
-
Monitoring hepatitis E virus fecal shedding to optimize ribavirin treatment duration in chronically infected transplant patients. J Hepatol. 2019 01; 70(1):206-209.
Score: 0.198
-
Conversion to Belatacept in Maintenance Kidney Transplant Patients: A Retrospective Multicenter European Study. Transplantation. 2018 09; 102(9):1545-1552.
Score: 0.196
-
Hepatitis E virus-associated cryoglobulinemia in solid-organ-transplant recipients. Liver Int. 2018 12; 38(12):2178-2189.
Score: 0.193
-
Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation. Transpl Infect Dis. 2018 Aug; 20(4):e12917.
Score: 0.193
-
Should Persistent Hepatitis E Virus Replication in Transplant Patients Be Tolerated? Transplantation. 2018 02; 102(2):e84-e85.
Score: 0.188
-
Unusual Pathology in a Kidney from a Heart-Transplant Patient. Case Rep Transplant. 2017; 2017:1084718.
Score: 0.185
-
Malignancies in hepatitis C virus-positive and -negative kidney transplant recipients: A case-controlled study. Transpl Infect Dis. 2017 Aug; 19(4).
Score: 0.181
-
Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated With Belatacept. Transplantation. 2021 09 01; 105(9):e94-e95.
Score: 0.060
-
The age-calibrated measured glomerular filtration rate improves living kidney donation selection process. Kidney Int. 2018 09; 94(3):616-624.
Score: 0.049
-
Eculizumab for Thrombotic Microangiopathy Associated with Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation. Case Rep Transplant. 2017; 2017:3197042.
Score: 0.047
-
Preemptive second kidney transplantation is associated with better graft survival compared with non-preemptive second transplantation: a multicenter French 2000-2014 cohort study. Transpl Int. 2018 04; 31(4):408-423.
Score: 0.047